| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/22/2004 | US20040077708 Atorvastatin calcium; bioavailability |
| 04/22/2004 | US20040077703 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/22/2004 | US20040077677 Oral formulations |
| 04/22/2004 | US20040077615 Novel formulations for administering therapeutic lipophilic molecules |
| 04/22/2004 | US20040077604 Reducing toxicity of nonsteroidal antiinflammatory drugs (NSAIDs) |
| 04/22/2004 | US20040077603 Synthetic tear fluid |
| 04/22/2004 | US20040077594 Included in cyclodextrin derivative; reducing irritation at intramuscular injection site |
| 04/22/2004 | US20040077592 Cross-linked polysaccharide drug carrier |
| 04/22/2004 | US20040077587 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/22/2004 | US20040077582 Cationic reagents for transfection |
| 04/22/2004 | US20040077562 Corticosteroid and quinolone or amino-glycoside derivative; post operative ophthalmic treatment |
| 04/22/2004 | US20040077560 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 04/22/2004 | US20040077559 Doxorubicin hydrochloride acidic solution which has not been reconstituted from lyophilizate |
| 04/22/2004 | US20040077552 Inflammation-inhibiting compounds |
| 04/22/2004 | US20040077540 Permeabilizing peptide; reversibly enhancing paracellular transport; inhibits homotypic binding |
| 04/22/2004 | US20040077533 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/22/2004 | US20040077528 Entrapping active agent in fumaryl diketopiperazine derivative and solvent washing out impurities; purified insulin for pulmonary administration |
| 04/22/2004 | US20040077513 Releasing deodorants at water surface of toilet bowl without accessing tank; avoids skin contact with harsh chemicals; water soluble polymer protective coating |
| 04/22/2004 | US20040077232 Pharmaceutical compositions |
| 04/22/2004 | US20040076991 Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity |
| 04/22/2004 | US20040076966 Encapsulating a solution for in vitro transcription/ translation reactions so that the reactions proceed inside said capsule. |
| 04/22/2004 | US20040076799 Method and device for producing thin wafers from a film of active ingredients |
| 04/22/2004 | US20040076683 Can be used for treatment of solid or circulating cancerous tumors; exhibit reduced toxicity compared to free drug in solution, exhibit stealth properties with respect to immune system of host to which they are administered |
| 04/22/2004 | US20040076682 Novel ophthalmic compositions |
| 04/22/2004 | US20040076681 Hollow tubular body comprising and second ends, wherein first end is open, end cap positioned over first open end, end cap attached to hollow tubular body by covalent bond and particle has maximum dimension of less than 100 mu m; drug delivery |
| 04/22/2004 | US20040076679 Gel delivery vehicles for anticellular proliferative agents |
| 04/22/2004 | US20040076678 Opthalmic solution |
| 04/22/2004 | US20040076676 Heat-melting polylactic acid having a weight-average molecular weight of 3,000-40,000 at 140-220 degrees C, cooling, pulverizing solidified polylactic acid, adding active materials, compressing powder in mold |
| 04/22/2004 | US20040076675 Composition improved in solubility or oral absorbability |
| 04/22/2004 | US20040076673 Oral pharmaceutical composition containing a block copolymer |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076671 Methods and compositions for topical wound treatment |
| 04/22/2004 | US20040076670 Process for producing pulverulent active substance formulations with compressible fluids |
| 04/22/2004 | US20040076669 Tramadol-based medicament |
| 04/22/2004 | US20040076668 Comprises PDE4D inhibitor, or pharmaceutically acceptable salt thereof, preferably (R)-2-(4-(((2-(benzo(1,3)dioxol-5-yloxy)-pyridine-3-carbonyl)-amino)-methyl)-3-fluoro-phenoxy)-propionic acid |
| 04/22/2004 | US20040076667 Sustained release pharmaceutical composition containing metformin hydrochloride |
| 04/22/2004 | US20040076666 Fast-dispersing dosage forms containing fish gelatin |
| 04/22/2004 | US20040076665 Modified release oral dosage form |
| 04/22/2004 | US20040076664 Chewable, soft gel, high potency vitamins and method of manufacture |
| 04/22/2004 | US20040076661 Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
| 04/22/2004 | US20040076658 Readily dispersible dietary fiber composition |
| 04/22/2004 | US20040076651 Degree of foam-up after storage in a container of at least one week at room temperature is </= 10% |
| 04/22/2004 | US20040076648 Antidepressant, an n-methyl-aspartic acid receptor antagonist, a lipophilic component, water and a surfacant; oil in water emulsion |
| 04/22/2004 | US20040076632 DNA vaccine against feline immunodeficiency virus |
| 04/22/2004 | US20040076624 Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections |
| 04/22/2004 | US20040076602 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 04/22/2004 | US20040076599 Keratin-based powders and hydrogel for pharmaceutical applications |
| 04/22/2004 | US20040076598 For moisturizing skin and/or mucous membranes; for treating hair/eyes |
| 04/22/2004 | US20040076589 Comprises albuterol/insulin; eliminates need for injections |
| 04/22/2004 | US20040076588 Inhalable epinephrine |
| 04/22/2004 | US20040076587 Such as 1-(N2-(3,5-dibromo-N-((4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1 -piperidinyl)carbonyl)-D-tyrosyl)-L-lysyl)-4-(4-pyridinyl)-piperazine; calcitonin gene related peptide (CGRP) |
| 04/22/2004 | US20040076586 For administration to tissues/mononuclear phagocytes/ macrophages; for treatment of inflammatory diseases/disorders |
| 04/22/2004 | US20040076585 Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers |
| 04/22/2004 | US20040076582 Comprises spherical/micronized polyvinyl alcohol particle containing radioactive species; monoclonal antibodies |
| 04/22/2004 | US20040075668 Subtitling transmission system |
| 04/22/2004 | US20040074503 Urine incontinenece device and corresponding method |
| 04/22/2004 | DE10247910A1 Oral appetite-suppressant comprises capsule of compressed Konjak meal which is insoluble in gastro-intestinal fluid, but swells in it |
| 04/22/2004 | DE10247037A1 Solid, rapid release dosage form, especially for sparingly soluble drugs, obtained by forming and cooling softened, shapable mixture of crosslinked non-thermoplastic carrier, adjuvant and active agent |
| 04/22/2004 | DE10246900A1 Am Auge applizierbare Vorrichtung zur sicheren Dosierung systemischer und tropischer Medikation On the eye Administered device for safe dosage of systemic and tropical medication |
| 04/22/2004 | DE10085492T5 Antimonocytenaktivität von extrakten von Betelpfefferblättern Antimonocytenaktivität of extracts of Betelpfefferblättern |
| 04/22/2004 | CA2501949A1 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | CA2501760A1 Nasally applicable pharmaceutical preparation and the production thereof |
| 04/22/2004 | CA2501614A1 Mucoadhesive tetracycline formulations |
| 04/22/2004 | CA2501345A1 Gastro-retentive levodopa delivery form |
| 04/22/2004 | CA2501133A1 Oral formulations for proteins and polypeptides |
| 04/22/2004 | CA2501132A1 Cyclodextrin-based materials, compositions and uses related thereto |
| 04/22/2004 | CA2500923A1 Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof |
| 04/22/2004 | CA2500908A1 Gamma irradiation of solid nanoparticulate active agents |
| 04/22/2004 | CA2500742A1 Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis |
| 04/22/2004 | CA2500375A1 Stabilized pharmaceutical composition containing basic excipients |
| 04/22/2004 | CA2500310A1 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 04/22/2004 | CA2498938A1 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 04/22/2004 | CA2498488A1 Solid particulate antifungal compositions for pharmaceutical use |
| 04/22/2004 | CA2482013A1 Process for preparing tannate tablet capsule or other solid dosage forms |
| 04/22/2004 | CA2465860A1 Methods and compositions for therapeutic use of rna interference |
| 04/21/2004 | EP1410820A2 Nasal delivery devices |
| 04/21/2004 | EP1410804A1 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 04/21/2004 | EP1410797A1 Solid oral dosage forms comprising valsartan |
| 04/21/2004 | EP1410794A1 Soft capsules |
| 04/21/2004 | EP1410793A1 Delivery form of sodium ibuprofen |
| 04/21/2004 | EP1410792A1 Microparticles |
| 04/21/2004 | EP1410791A1 Orally administrable galenic form comprising metformine and an absorption-promoting agent |
| 04/21/2004 | EP1410790A1 Submicron-liposome containing triterpenoid and a method for preparing the same |
| 04/21/2004 | EP1410721A1 Process for manufacturing a palatinose-containing enteral food |
| 04/21/2004 | EP1409701A2 Fluorescently labelled locked nucleic acids |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409602A1 Pyrrolidonoethyl (meth) acrylate containing pressure sensitive adhesive compositions |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409494A1 Stabilized derivatives of ascorbic acid -3- phosphate |
| 04/21/2004 | EP1409474A1 Method for the production of dronabinol |
| 04/21/2004 | EP1409443A2 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same |
| 04/21/2004 | EP1409149A1 Method and device for coating pharmaceutical products |
| 04/21/2004 | EP1409140A1 Drug activation process and vibrational mill therefor |
| 04/21/2004 | EP1409123A1 Method and apparatus for preparing particles |
| 04/21/2004 | EP1409101A1 Formation of small crystals |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409050A2 Apparatus for self-induced cough-cardiopulmonary resuscitation |